Ireland
--:--IST
Recruiting Phase 3

Advancing Brain Outcomes in Pediatric Critically Ill Patients Sedated With Volatile AnEsthestic Agents

NCT05867472 · tracked via the Priya Life Science Canada tracker
Phase
Phase 3
Started
2023-10-10
Last updated
2026-02-04

Condition(s) studied

Intensive Care Units, PediatricAnesthetics, InhalationMechanically Ventilated, Critically Ill Children

Investigational drug(s) / intervention(s)

Isoflurane Inhalant Product →

Isoflurane Inhalant Product: Isoflurane will be administered using an inhalation device

Study summary

The goal of a pilot study is to test a study plan to see if it is appropriate for a larger study. This study plan is looking at whether the use of inhaled sedatives (medications that help people be calm and sleep) can reduce delirium (extreme confusion) in children who need a ventilator (breathing machine) compared to IV or oral sedatives.

The main question\[s\] it aims to answer are:

* Will people join the study? (recruitment)
* Will participants finish the study?
* Will healthcare teams accept the study procedures?

Participants will be randomized to receive study treatment (inhaled sedation) or standard of care (IV sedation). They will be monitored daily for up to 28 days. They will complete memory, thinking and behaviour tasks after 9-12 months.

Eligibility

Sex
ALL
Min age
1 Month
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria: 1. Pediatric patients age from 1 month to less than 18 years who need sedation to tolerate mechanical ventilation and will remain ventilated for ≥ 24 hours 2. Receiving IV sedation by infusion or bolus for ≤72h to aid mechanical ventilation (but will be recruited as early as possible) Exclusion Criteria: 1. Current use of inhaled prostacyclin (high viscosity of prostacyclin impairs vaporizer device) or continuous salbutamol nebulization (impairs gas analyzer function) 2. Family history or personal history of malignant hyperthermia (MH) 3. Allergy to isoflurane, sevoflurane or other volatile inhaled anesthetic gas 4. Metabolic, mitochondrial or myopathy disease e.g., Duchenne muscular dystrophy (volatiles may trigger malignant hyperthermia like reaction) 5. Moribund with expected survival \< 24h 6. Known pregnancy or lactation 7. Suspected or evidence of high intracranial pressure (ICP) 8. Not a 'closed ventilator circuit' with potential for gas leak (e.g. uncuffed ETT, bronchopleural fistula, tracheal/trachea-esophageal fistulas, or other sources of "gas leak" from patient circuit that cannot be removed) 9. Prior enrollment in the ABOVE trial

Primary outcome measure(s)

  • Participant recruitment — 2 years
    Accrual and/or identification of challenges in accruing 60 mechanically ventilated participants (age 1 month to 18 years).

Trial sites (3)

FacilityCityRegionStatus
McMaster Children's Hospital Hamilton Ontario Recruiting
Children's Hospital - London Health Sciences Centre London Ontario Recruiting
The Hospital for Sick Children (SickKids) Toronto Ontario Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05867472 on ClinicalTrials.gov ↗ ← All trials in Canada